Who Was Missing From the Room: Confronting the Representation Crisis at Global Dermatology Summits

When delegates gathered in Vienna in 2020 for one of dermatology's most consequential international forums, a troubling pattern emerged in the hallways and lecture theaters: the field's growing diversity at home was not reflected among those who had made the journey. For Black, Latino, and Asian American dermatologists in the United States, the barriers to international conference participation are neither incidental nor invisible—they are structural, financial, and deeply consequential for the future of the discipline.

A Room That Didn't Reflect the Profession It Represented

Dermatology in the United States has spent much of the past decade engaging in pointed self-examination about who enters the specialty, who advances within it, and whose patients receive equitable care. Yet the conversations happening at the highest levels of global exchange—at forums like EADV Vienna 2020—have frequently unfolded without the voices of physicians from historically underrepresented backgrounds. Informal surveys of American attendees and candid accounts shared in the margins of the conference suggest that dermatologists of color constituted a fraction of the U.S. delegation, a disproportion that mirrors longstanding structural inequities rather than any deficiency of interest or qualification.

The significance of this absence is difficult to overstate. International conferences are not merely networking events; they are sites where research agendas are shaped, collaborative studies are conceived, and the intellectual direction of a specialty is negotiated. When certain practitioners are systematically excluded from those conversations, the consequences extend far beyond any individual career.

The Financial Architecture of Exclusion

Attending a major international dermatology symposium carries a price tag that few openly acknowledge. Transatlantic airfare, conference registration, hotel accommodation in a European capital, and incidental expenses can collectively exceed $5,000 for a single physician—and that figure does not account for the income foregone during days away from clinical practice. For dermatologists in private practice, particularly those in the early stages of building a patient base, the cost is prohibitive. For those carrying significant medical school debt—a burden that falls disproportionately on Black and Latino physicians, who are statistically more likely to have financed their education without family wealth—the calculation is even more stark.

Institutional support, when it exists, is distributed unevenly. Academic medical centers with endowed research programs frequently subsidize international travel for their faculty, but these positions are not equally accessible across demographic lines. A 2019 analysis of academic dermatology faculty composition found that Black dermatologists represented fewer than 3 percent of full-time faculty at U.S. medical schools—a figure that directly constrains access to the institutional resources that make international conference attendance financially feasible.

The Pipeline Problem and Its Global Dimension

The underrepresentation observed at Vienna 2020 is, in one sense, a downstream consequence of a pipeline that narrows at every stage for physicians from underrepresented backgrounds. Dermatology remains among the most competitive specialties in American medicine, with match rates and board scores that can disadvantage applicants who lacked access to elite research opportunities or mentorship networks during medical school. Those who do successfully navigate the specialty's gatekeeping mechanisms then enter a professional landscape in which advancement—including the kind of international visibility that conference attendance enables—continues to favor those with pre-existing social capital.

What makes the international dimension particularly consequential is that global symposiums function as accelerants for careers. Physicians who present research in Vienna, who establish collaborative relationships with European colleagues, and who participate in the informal knowledge exchanges that define these events return home with advantages that compound over time. Publications, grant opportunities, and leadership nominations frequently trace their origins to chance encounters in conference corridors. The absence of dermatologists of color from these spaces does not merely reflect existing inequity—it actively reproduces it.

Skin of Color Research and the Costs of Exclusion

Beyond the career implications for individual physicians, the demographic composition of international conferences has direct consequences for the research questions that receive attention and resources. Dermatology has been slow to develop robust clinical evidence for patients with darker skin tones. Conditions including keloids, pseudofolliculitis barbae, melasma, and the presentation of common inflammatory diseases in skin of color have historically been underrepresented in clinical literature, a gap that practitioners who treat racially diverse patient populations navigate daily.

Physicians from underrepresented backgrounds are disproportionately likely to work in communities of color and to bring firsthand clinical insight into the dermatological needs of those patients. Their exclusion from global research dialogues means that the questions most relevant to those communities are less likely to be raised, less likely to receive funding, and less likely to find their way into the international literature that shapes clinical standards worldwide. The intellectual cost of homogeneous conference attendance is, ultimately, borne by patients.

What Accountability Looks Like

Several professional organizations have begun to acknowledge the structural nature of these barriers, moving beyond aspirational diversity statements toward concrete interventions. Travel grant programs specifically targeting underrepresented dermatologists, mentorship pipelines that connect early-career physicians of color with established international researchers, and deliberate recruitment of diverse speakers for plenary sessions represent meaningful—if insufficient—steps.

For American dermatology societies considering how to engage with future international forums, the lesson of Vienna 2020 is not simply that more diverse attendees should be encouraged to attend. It is that the conditions making attendance possible—financial support, institutional sponsorship, and the social networks that translate conference participation into career advancement—must be actively redistributed. Diversity in the room is an outcome; equity in the systems that determine who enters the room is the prerequisite.

Moving the Conversation Forward

The dialogues that EADV Vienna 2020 facilitated across borders and disciplines were, by most measures, substantive and consequential. The presentations delivered, the research collaborations initiated, and the clinical insights exchanged have continued to reverberate through American dermatology in the years since. But the full potential of that global dialogue was constrained by who was present to participate in it.

Dermatology's ambitions as a discipline—to advance care for all patients, to build a leadership pipeline that reflects the populations it serves, and to conduct research that addresses the full spectrum of human skin—cannot be realized through conversations among a narrow demographic slice of its practitioners. The question Vienna 2020 posed, perhaps unintentionally, is whether the field is prepared to treat representation at its highest forums not as a courtesy, but as a clinical and scientific imperative.